We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Sniper Medical Technology Stock

Invest in or calculate the value of your shares in Sniper Medical Technology or other pre-IPO companies through EquityZen's platform.

Get Started

Sniper Medical Technology Stock (SNMT)

Sniper develops accurate and intelligent molecular diagnostic solutions.

About Sniper Medical Technology Stock

Founded

2018

Industries

Software, Artificial Intelligence, Data and Analytics

Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generation technology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.

Sniper Medical Technology Press Mentions

Stay in the know about the latest news on Sniper Medical Technology

Sniper Medical Technology Management

Leadership team at Sniper Medical Technology

Founder

Guangji Sheng

Locked Features

Join now and verify your accreditation status to gain access to:

  • Sniper Medical Technology Current Valuation
  • Sniper Medical Technology Stock Price
  • Sniper Medical Technology Management
  • Available deals in Sniper Medical Technology and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Sniper Medical Technology Cap Table and Funding History by Share Class and Liquidity Preferences
    • Sniper Medical Technology Revenue and Financials
    • Sniper Medical Technology Highlights
    • Sniper Medical Technology Business Model
    • Sniper Medical Technology Risk Factors
  • Sniper Medical Technology Research Report from SACRA Research
Join Now

Trading Sniper Medical Technology Stock

How to invest in Sniper Medical Technology stock?

Accredited investors can buy pre-IPO stock in companies like Sniper Medical Technology through EquityZen funds. These investments are made available by existing Sniper Medical Technology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Sniper Medical Technology stock?

Shareholders can sell their Sniper Medical Technology stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."